IBDEI2XV ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,46900,0)
 ;;=T81.41XS^^179^2338^33
 ;;^UTILITY(U,$J,358.3,46900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46900,1,3,0)
 ;;=3^Infect Following Proced,Superfic Incis Surg Site,Sequela
 ;;^UTILITY(U,$J,358.3,46900,1,4,0)
 ;;=4^T81.41XS
 ;;^UTILITY(U,$J,358.3,46900,2)
 ;;=^5157589
 ;;^UTILITY(U,$J,358.3,46901,0)
 ;;=T81.42XA^^179^2338^22
 ;;^UTILITY(U,$J,358.3,46901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46901,1,3,0)
 ;;=3^Infect Following Proced,Deep Incis Surg Site,Init
 ;;^UTILITY(U,$J,358.3,46901,1,4,0)
 ;;=4^T81.42XA
 ;;^UTILITY(U,$J,358.3,46901,2)
 ;;=^5157590
 ;;^UTILITY(U,$J,358.3,46902,0)
 ;;=T81.42XD^^179^2338^23
 ;;^UTILITY(U,$J,358.3,46902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46902,1,3,0)
 ;;=3^Infect Following Proced,Deep Incis Surg Site,Subs
 ;;^UTILITY(U,$J,358.3,46902,1,4,0)
 ;;=4^T81.42XD
 ;;^UTILITY(U,$J,358.3,46902,2)
 ;;=^5157591
 ;;^UTILITY(U,$J,358.3,46903,0)
 ;;=T81.42XS^^179^2338^24
 ;;^UTILITY(U,$J,358.3,46903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46903,1,3,0)
 ;;=3^Infect Following Proced,Deep Incis Surg Site,Sequela
 ;;^UTILITY(U,$J,358.3,46903,1,4,0)
 ;;=4^T81.42XS
 ;;^UTILITY(U,$J,358.3,46903,2)
 ;;=^5157592
 ;;^UTILITY(U,$J,358.3,46904,0)
 ;;=T81.43XA^^179^2338^25
 ;;^UTILITY(U,$J,358.3,46904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46904,1,3,0)
 ;;=3^Infect Following Proced,Organ/Space Surg Site,Init
 ;;^UTILITY(U,$J,358.3,46904,1,4,0)
 ;;=4^T81.43XA
 ;;^UTILITY(U,$J,358.3,46904,2)
 ;;=^5157593
 ;;^UTILITY(U,$J,358.3,46905,0)
 ;;=T81.43XD^^179^2338^26
 ;;^UTILITY(U,$J,358.3,46905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46905,1,3,0)
 ;;=3^Infect Following Proced,Organ/Space Surg Site,Subs
 ;;^UTILITY(U,$J,358.3,46905,1,4,0)
 ;;=4^T81.43XD
 ;;^UTILITY(U,$J,358.3,46905,2)
 ;;=^5157594
 ;;^UTILITY(U,$J,358.3,46906,0)
 ;;=T81.43XS^^179^2338^27
 ;;^UTILITY(U,$J,358.3,46906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46906,1,3,0)
 ;;=3^Infect Following Proced,Organ/Space Surg Site,Sequela
 ;;^UTILITY(U,$J,358.3,46906,1,4,0)
 ;;=4^T81.43XS
 ;;^UTILITY(U,$J,358.3,46906,2)
 ;;=^5157595
 ;;^UTILITY(U,$J,358.3,46907,0)
 ;;=T81.49XA^^179^2338^28
 ;;^UTILITY(U,$J,358.3,46907,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46907,1,3,0)
 ;;=3^Infect Following Proced,Oth Surg Site,Init
 ;;^UTILITY(U,$J,358.3,46907,1,4,0)
 ;;=4^T81.49XA
 ;;^UTILITY(U,$J,358.3,46907,2)
 ;;=^5157599
 ;;^UTILITY(U,$J,358.3,46908,0)
 ;;=T81.49XD^^179^2338^29
 ;;^UTILITY(U,$J,358.3,46908,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46908,1,3,0)
 ;;=3^Infect Following Proced,Oth Surg Site,Subs
 ;;^UTILITY(U,$J,358.3,46908,1,4,0)
 ;;=4^T81.49XD
 ;;^UTILITY(U,$J,358.3,46908,2)
 ;;=^5157600
 ;;^UTILITY(U,$J,358.3,46909,0)
 ;;=T81.49XS^^179^2338^30
 ;;^UTILITY(U,$J,358.3,46909,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46909,1,3,0)
 ;;=3^Infect Following Proced,Oth Surg Site,Sequela
 ;;^UTILITY(U,$J,358.3,46909,1,4,0)
 ;;=4^T81.49XS
 ;;^UTILITY(U,$J,358.3,46909,2)
 ;;=^5157601
 ;;^UTILITY(U,$J,358.3,46910,0)
 ;;=D29.1^^179^2339^5
 ;;^UTILITY(U,$J,358.3,46910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46910,1,3,0)
 ;;=3^Benign neoplasm of prostate
 ;;^UTILITY(U,$J,358.3,46910,1,4,0)
 ;;=4^D29.1
 ;;^UTILITY(U,$J,358.3,46910,2)
 ;;=^267657
 ;;^UTILITY(U,$J,358.3,46911,0)
 ;;=N40.0^^179^2339^4
 ;;^UTILITY(U,$J,358.3,46911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46911,1,3,0)
 ;;=3^BPH (enlarged prostate) w/o LUTS
